Impact of Testosterone on Aspects of Psychology
This chapter explores what we know about the psychological effects of testosterone in women, both with polycystic ovary syndrome (PCOS) and without. Many readers will find this chapter fascinating. The topics include ones that people might think they know about, but are widely misunderstood, such as sexual orientation and aggression. There are other topics in which testosterone has the expected impact on healthy women (such as cognition and libido), but works differently in women with PCOS. There are many surprises in this chapter, not least the evidence that testosterone, a prosocial hormone.
KeywordsMental rotation Libido Sexual orientation Aggression Prosocial
- Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., … Witchel, S. F. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertility and Sterility, 91(2), 456–488.PubMedPubMedCentralCrossRefGoogle Scholar
- Barry, J. A., Leite, N., Sivarajah, N., Keevil, B., Owen, L., Miranda, L. C., … Hardiman, P. (2017). Relaxation and guided imagery significantly reduces androgen levels and distress in polycystic ovary syndrome: Pilot study. Contemporary Hypnosis and Integrative Therapy, 32(1), 21–29.Google Scholar
- Batool, S., ul ain Ahmed, F., Ambreen, A., Sheikh, A., & Faryad, N. (2016). Depression and anxiety in women with polycystic ovary syndrome and its biochemical associates. Journal of South Asian Federation of Obstetrics and Gynaecology, 8(1), 44–47.Google Scholar
- Borghi, L., Leone, D., Vegni, E., Galiano, V., Lepadatu, C., Sulpizio, P., & Garzia, E. (2018). Psychological distress, anger and quality of life in polycystic ovary syndrome: Associations with biochemical, phenotypical and socio-demographic factors. Journal of Psychosomatic Obstetrics and Gynecology, 39(2), 128–137.PubMedPubMedCentralCrossRefGoogle Scholar
- Davis, S. (2001). Testosterone treatment: Psychological and physical effects in postmenopausal women. American Society for Reproductive Medicine: Menopausal Medicine, 9(2).Google Scholar
- Defreyne, J., Kreukels, B., T’Sjoen, G., Stahporsius, A., Den Heijer, M., Heylens, G., & Elaut, E. (2019). No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence. Hormones and Behavior, 110, 29–39.CrossRefGoogle Scholar
- Dunphy, L. (2018, January 18). Lesbian mum who viciously beat bride walks free after telling court she has high levels of “male hormones”. Retrieved from https://www.mirror.co.uk/news/uk-news/lesbian-mum-who-viciously-beat-11872183#ICID=sharebar_twitter.
- Elsenbruch, S., Hahn, S., Kowalsky, D., Offner, A. H., Schedlowski, M., Mann, K., & Janssen, O. E. (2003). Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 88, 5801–5807.PubMedPubMedCentralCrossRefGoogle Scholar
- Gul, A., Gul, H., Ergur, A. T., & Ozen, N. E. (2018). Anxiety-anger relationship in hyperandrogenemia: A comparative study with polycystic ovary syndrome (PCOS) and healthy control adolescents. Journal of Mood Disorders, 8(1), 26–31.Google Scholar
- Legro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., … Ohl, D. (2010). Total testosterone assays in women with polycystic ovary syndrome: Precision and correlation with hirsutism. The Journal of Clinical Endocrinology & Metabolism, 95(12), 5305–5313.CrossRefGoogle Scholar
- McCook, J. G. (2002). The influence of hyperandrogenism, obesity and infertility on the psychosocial health and wellbeing of women with polycystic ovary syndrome. Unpublished doctoral dissertation, University of Michigan.Google Scholar
- Monzani, F., Pucci, F., Caraccio, N., Bagnolesi, A., Molli, D., Fenu, A., & Prunetti, C. (1994). Psychological and psychopathological correlates in the polycystic ovary syndrome (PCOS). Medicina Psicosomatica, 39, 225–236.Google Scholar
- Nathorst-Böös, J., Flöter, A., Jarkander-Rolff, M., Carlström, K., & Von Schoultz, B. (2006). Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido–effects on sexuality and psychological general well-being. Maturitas, 53(1), 11–18.PubMedCrossRefPubMedCentralGoogle Scholar
- Roche Diagnostics. (2000). Elecsys Testosterone Product Information. Retrieved May 5, 2010, from http://www.roche-diagnostics.ch/resource.php?id=Resourcefile-37084379e9754cf58.
- Sills, E. S., Perloe, M., Tucker, M. J., Kaplan, C. R., Genton, M. G., & Schattman, G. L. (2001). Diagnostic and treatment characteristics of polycystic ovary syndrome: Descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Women’s Health, 1(1), 3.PubMedPubMedCentralCrossRefGoogle Scholar
- Smith, A. M., Rissel, C. E., Richters, J., Grulich, A. E., & de Visser, R. O. (2003). Sex in Australia: Sexual identity, sexual attraction and sexual experience among a representative sample of adults. Australian and New Zealand Journal of Public Health, 27(2), 138–145.Google Scholar
- Taher, S., Rothon, C., & Panay, N. (2008). Testosterone gel and improvement in libido, psychological state and general wellbeing in natural and surgical post-menopausal women: P3. 24. Bjog: An International Journal of Obstetrics and Gynaecology, 115(187).Google Scholar
- Udiawar, M. (2017). Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome. Doctoral dissertation, Cardiff University.Google Scholar